Pharmacy Medical News about ITP

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Analysis of the impact and burden of illness of adult chronic ITP in the US
Current Medical Research and Opinion, 11/06/09

Grotzinger KM et al. – There is a need for patient–directed care plans, fuller consideration of available treatments, and the potential reduction in patient burden of illness. Study limitations included a broadly defined cohort and possible underreporting of certain medications. Introduction of highly effective and well–tolerated medications may reduce the cost and resource burden of ITP on the healthcare system.

<< Previous
Genetic modulation of the pharmacological treatment of pain

Next >>
Antibiotic or bacterial therapy in post-giardiasis irritable...

Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia
International Journal of Hematology, 10/13/09 Relevance Score: 84%

The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia
Blood, 10/02/09 Relevance Score: 84%

Medical treatments for idiopathic thrombocytopenic purpura during pregnancy
Cochrane Reviews, 10/27/09 Relevance Score: 82%

Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children
Annals of Hematology, 10/23/09 Relevance Score: 82%

Efficacy and safety of anti-D for treatment of adults with immune thrombocytopenia
Platelets, 10/30/09 Relevance Score: 80%